`

Cleveland Biolabs

Biotechnology Research

Specialities :
Oncology
Radiation countermeasure
And orphan drugs
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$14.0M
size-icon Size
11 - 50

Frequently Asked Questions About Cleveland Biolabs

What does Cleveland biolabs do?+

Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a clinical-stage biotechnology company with a focus on oncology and orphan drug development. Since our inception in 2003, we have pursued the research, development and commercialization of proprietary products that have the potential to treat cancer, prevent and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Presently, we have nine product candidates in our pipeline that are being developed directly by us and our majority-owned subsidiaries, Incuron, LLC and Panacela Labs, Inc

What are Cleveland biolabs's specialties? +

Oncology,radiation countermeasure,and orphan drugs

What is Cleveland biolabs's industry? +

Cleveland biolabs operates in the Biotechnology research industry.

What is Cleveland biolabs's revenue? +

Cleveland biolabs's revenue is 11m - 100m

What is Cleveland biolabs's company size? +

Cleveland biolabs has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.